Brainomix vs VUNO

Brainomix goes to a stroke service, while VUNO goes to a neurology practice tracking white matter disease or a radiology department reading chest X-rays. Both touch the chest, Brainomix with e-Lung on CT and VUNO with X-ray triage.

VUNO is a Seoul company listed on KOSDAQ since February 2021. Its FDA clearances are Med-DeepBrain (K231398, October 2023), which quantifies brain structures and lesions from MR, and Med-Chest X-ray Triage (K241439, November 2024), which covers adult chest X-rays for pleural effusion and/or pneumothorax. The vendor's chest page describes five major findings, a wider list than the FDA decision. A 2022 PLoS One study of DeepBrain white matter hyperintensity segmentation against Fazekas classification reports 96.4% sensitivity and 89.9% specificity for moderate or severe volume.

Brainomix offers smartphone alerts for suspected LVO and ICH on NCCT, ASPECTS, CTA collateral scores and CTP mismatch. A 2024 real-world evaluation in Stroke Vasc Neurol covered 1,130 scans, with 97.2% processed in about four minutes. A stroke neurology team working from CT and MRI is its buyer.